Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

The revised 2022 European LeukemiaNet (ELN) AML risk stratification system requires validation in large, homogeneously treated cohorts. We studied 1118 newly diagnosed AML patients (median age, 58 years; range, 18–86 years) who received cytarabine-based induction chemotherapy between 1999 and 2012 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rausch, Christian, Rothenberg-Thurley, Maja, Dufour, Annika, Schneider, Stephanie, Gittinger, Hanna, Sauerland, Cristina, Görlich, Dennis, Krug, Utz, Berdel, Wolfgang E., Woermann, Bernhard J., Hiddemann, Wolfgang, Braess, Jan, von Bergwelt-Baildon, Michael, Spiekermann, Karsten, Herold, Tobias, Metzeler, Klaus H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244159/
https://www.ncbi.nlm.nih.gov/pubmed/37041198
http://dx.doi.org/10.1038/s41375-023-01884-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244159/
https://www.ncbi.nlm.nih.gov/pubmed/37041198
http://dx.doi.org/10.1038/s41375-023-01884-2

Ejemplares similares